Koichi Suyama

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

K. Yamazaki, Michitaka Nagase, H Tamagawa et al. · Annals of Oncology · 2016 · 274 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +9

Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells

Daisuke Hashimoto, Masaki Ohmuraya, Masahiko Hirota et al. · The Journal of Cell Biology · 2008 · 217 citations · Full text

Prognostic value of programmed death‐ligand 1 expression in patients with stage <scp>III</scp> colorectal cancer

Shigehiro Koganemaru, Naoko Inoshita, Yuji Miura et al. · Cancer Science · 2017 · 53 citations · Full text

Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction

Daisuke Sueta, Koichi Suyama, Aiko Sueta et al. · Atherosclerosis · 2017 · 44 citations

Hypertension, Vascular Endothelial Dysfunction, Cardiovascular Disease +13

C/EBP homologous protein is crucial for the acceleration of experimental pancreatitis

Koichi Suyama, Masaki Ohmuraya, Masahiko Hirota et al. · Biochemical and Biophysical Research Communications · 2008 · 38 citations

Protein Function, Signal Transduction, Biochemistry +9